- Home
- ARCT vs FLX Comparison
ARCT vs FLX Comparison
Compare ARCT & FLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- FLX
- Stock Information
- Founded
- ARCT 2013
- FLX 2013
- Country
- ARCT United States
- FLX China
- Employees
- ARCT N/A
- FLX N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- FLX
- Sector
- ARCT Health Care
- FLX
- Exchange
- ARCT Nasdaq
- FLX NYSE
- Market Cap
- ARCT 298.3M
- FLX N/A
- IPO Year
- ARCT N/A
- FLX 2024
- Fundamental
- Price
- ARCT $13.78
- FLX $3.32
- Analyst Decision
- ARCT Strong Buy
- FLX
- Analyst Count
- ARCT 8
- FLX 0
- Target Price
- ARCT $52.83
- FLX N/A
- AVG Volume (30 Days)
- ARCT 474.9K
- FLX 86.7K
- Earning Date
- ARCT 08-04-2025
- FLX 08-27-2025
- Dividend Yield
- ARCT N/A
- FLX N/A
- EPS Growth
- ARCT N/A
- FLX N/A
- EPS
- ARCT N/A
- FLX N/A
- Revenue
- ARCT $143,680,000.00
- FLX $595,490,250.00
- Revenue This Year
- ARCT N/A
- FLX N/A
- Revenue Next Year
- ARCT $34.79
- FLX N/A
- P/E Ratio
- ARCT N/A
- FLX N/A
- Revenue Growth
- ARCT 15.38
- FLX N/A
- 52 Week Low
- ARCT $8.04
- FLX $2.01
- 52 Week High
- ARCT $25.88
- FLX $21.95
- Technical
- Relative Strength Index (RSI)
- ARCT 54.34
- FLX N/A
- Support Level
- ARCT $13.10
- FLX N/A
- Resistance Level
- ARCT $15.20
- FLX N/A
- Average True Range (ATR)
- ARCT 1.02
- FLX 0.00
- MACD
- ARCT 0.07
- FLX 0.00
- Stochastic Oscillator
- ARCT 55.21
- FLX 0.00
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.